Primary sclerosing cholangitis

GM Hirschfield, TH Karlsen, KD Lindor, DH Adams - The Lancet, 2013 - thelancet.com
Primary sclerosing cholangitis is the classic hepatobiliary manifestation of inflammatory
bowel disease and is generally chronic and progressive. Patients frequently present with …

Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management

JE Eaton, JA Talwalkar, KN Lazaridis, GJ Gores… - Gastroenterology, 2013 - Elsevier
Primary sclerosing cholangitis (PSC), first described in the mid-1850s, is a complex liver
disease that is heterogeneous in its presentation. PSC is characterized by chronic …

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations

G Van Assche, A Dignass, B Bokemeyer… - Journal of Crohn's …, 2013 - academic.oup.com
Second European evidence-based consensus on the diagnosis and management of ulcerative
colitis Part 3: Special situations | Journal of Crohn's and Colitis | Oxford Academic Skip to …

Improvement of serum alkaline phosphatase to< 1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing …

S Al Mamari, J Djordjevic, JS Halliday… - Journal of hepatology, 2013 - Elsevier
BACKGROUND & AIMS: Normalization of serum alkaline phosphatase (SAP) was recently
shown to correlate with better prognosis in Primary Sclerosing Cholangitis (PSC). We aimed …

Autoimmune hepatitis: contrasts and comparisons in children and adults–a comprehensive review

A Floreani, R Liberal, D Vergani, G Mieli-Vergani - Journal of autoimmunity, 2013 - Elsevier
This review concentrates on autoimmune hepatitis (AIH), a liver disorder affecting both
children and adults, characterized by inflammatory liver histology, elevated transaminase …

Primary sclerosing cholangitis: a review and update on therapeutic developments

JH Tabibian, KD Lindor - Expert review of gastroenterology & …, 2013 - Taylor & Francis
Primary sclerosing cholangitis (PSC) is a chronic, cholestatic, idiopathic liver disease
characterized by fibro-obliterative inflammation of the hepatic bile ducts. In a clinically …

Treatment of autoimmune liver disease: current and future therapeutic options

PJ Trivedi, GM Hirschfield - Therapeutic advances in chronic …, 2013 - journals.sagepub.com
Autoimmune liver disease spans three predominant processes, from the interface hepatitis
of autoimmune hepatitis to the lymphocytic cholangitis of primary biliary cirrhosis, and finally …

Glucocorticoid receptor-dependent immunomodulatory effect of ursodeoxycholic acid on liver lymphocytes in mice

T Takigawa, H Miyazaki, M Kinoshita… - American Journal …, 2013 - journals.physiology.org
Although ursodeoxycholic acid (UDCA) has long been used for patients with chronic
cholestatic liver diseases, particularly primary biliary cirrhosis, it may modulate the host …

Guidelines for the management of ulcerative colitis. Recommendations of the Working Group of the Polish National Consultant in Gastroenterology and the Polish …

P Eder, M Łodyga, L Łykowska-Szuber… - Gastroenterology …, 2013 - termedia.pl
Metodologia Niniejsze opracowanie zawiera 38 stwierdzeń dotyczących objawów, kryteriów
rozpoznania oraz postępowania terapeutycznego w WZJG. Są one oparte na wynikach …

Overlap syndromes of autoimmune hepatitis: an open question

M Durazzo, A Premoli, E Paschetta, P Belci… - Digestive diseases and …, 2013 - Springer
The headword “overlap syndromes” of liver diseases includes the coexistence of
autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis. These …